PERSPECTA

News from every angle

Back to headlines

Arcutis Biotherapeutics Spotlights ZORYVE Surge, 2025 Revenue Beat and Key FDA Milestones at TD Cowen

4 Mar, 13:09 — 4 Mar, 13:09
PostShare

Sources

Showing 1 of 1 sources